Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology.

The review gives first an introduction into the basics of surface plasmon resonance technology. The physical principle is shortly discussed followed by a discussion of the experimental details to be considered when using this technology for biomolecular interaction analysis. Based on recent publications it is demonstrated that the technology has widespread applications in many fields of the drug discovery process. Protein/protein interactions can be monitored in real time when working with biopharmaceuticals as well as protein/small analyte interactions during hit finding, secondary screening, lead optimization and lead selection. Equilibrium binding constants, kinetic rate constants and thermodynamic parameters are obtained from such study that helps to understand the mechanism of the binding reactions. This information can be directly used to improve binding properties of a drug candidate.

[1]  J. Ladbury,et al.  Survey of the year 2005: literature on applications of isothermal titration calorimetry , 2007, Journal of molecular recognition : JMR.

[2]  Rebecca L Rich,et al.  Survey of the year 2003 commercial optical biosensor literature , 2005, Journal of molecular recognition : JMR.

[3]  Martin G Pomper,et al.  Small animal imaging in drug development. , 2005, Current pharmaceutical design.

[4]  A. Leson “There is plenty of room at the Bottom”. , 2005 .

[5]  H. Koga,et al.  A novel approach to protein expression profiling using antibody microarrays combined with surface plasmon resonance technology , 2005, Proteomics.

[6]  Walter Huber,et al.  A new strategy for improved secondary screening and lead optimization using high‐resolution SPR characterization of compound–target interactions , 2005, Journal of molecular recognition : JMR.

[7]  Helena Nordin,et al.  Kinetic studies of small molecule interactions with protein kinases using biosensor technology. , 2005, Analytical biochemistry.

[8]  T. Carlomagno Ligand-target interactions: what can we learn from NMR? , 2005, Annual review of biophysics and biomolecular structure.

[9]  Alfred Ross,et al.  Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2. , 2005, Bioconjugate chemistry.

[10]  Andrew M Davis,et al.  Components of successful lead generation. , 2005, Current topics in medicinal chemistry.

[11]  Peter M Fischer,et al.  Strategies for the design of potent and selective kinase inhibitors. , 2005, Current pharmaceutical design.

[12]  David G Myszka,et al.  Solubilization, stabilization, and purification of chemokine receptors using biosensor technology. , 2005, Analytical biochemistry.

[13]  U. H. Danielson,et al.  Early absorption and distribution analysis of antitumor and anti-AIDS drugs: lipid membrane and plasma protein interactions. , 2005, Journal of medicinal chemistry.

[14]  H. van de Waterbeemd,et al.  Biosensor analysis of the interaction between drug compounds and liposomes of different properties; a two-dimensional characterization tool for estimation of membrane absorption. , 2005, Journal of pharmaceutical sciences.

[15]  Rebecca L Rich,et al.  Why you should be using more SPR biosensor technology. , 2004, Drug discovery today. Technologies.

[16]  Wolfgang Jahnke,et al.  New approaches for NMR screening in drug discovery. , 2004, Drug discovery today. Technologies.

[17]  J. E. Brewer,et al.  High-affinity small molecule inhibitors of T cell costimulation: compounds for immunotherapy. , 2004, Chemistry & biology.

[18]  U Helena Danielson,et al.  Improved structure-activity relationship analysis of HIV-1 protease inhibitors using interaction kinetic data. , 2004, Journal of medicinal chemistry.

[19]  Walter Huber,et al.  SPR-based interaction studies with small molecular weight ligands using hAGT fusion proteins. , 2004, Analytical biochemistry.

[20]  S. Loefas,et al.  Optimizing the hit-to-lead process using SPR analysis. , 2004, Assay and drug development technologies.

[21]  Young‐Tae Chang,et al.  Tools for target identification and validation. , 2004, Current opinion in chemical biology.

[22]  Jean-Louis Reymond,et al.  Enzyme assays for high-throughput screening. , 2004, Current opinion in biotechnology.

[23]  Tudor I. Oprea,et al.  Flow cytometry for high-throughput, high-content screening. , 2004, Current opinion in chemical biology.

[24]  Melanie H. Wong,et al.  Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technology. , 2004, Analytical biochemistry.

[25]  David G Myszka,et al.  Analysis of small-molecule interactions using Biacore S51 technology. , 2004, Analytical biochemistry.

[26]  Michael Frank,et al.  Production and Storage of High-Density Chemical Microarrays , 2004 .

[27]  D. Myszka,et al.  Probing the mechanism of drug/lipid membrane interactions using Biacore. , 2004, Analytical biochemistry.

[28]  Tingjun Hou,et al.  Recent development and application of virtual screening in drug discovery: an overview. , 2004, Current pharmaceutical design.

[29]  U Helena Danielson,et al.  Kinetic and thermodynamic characterization of HIV‐1 protease inhibitors , 2004, Journal of molecular recognition : JMR.

[30]  Steven J. Swanson,et al.  Evaluation of Methods to Detect and Characterize Antibodies against Recombinant Human Erythropoietin , 2004, Nephron Clinical Practice.

[31]  David G Myszka,et al.  Kinetic screening of antibodies from crude hybridoma samples using Biacore. , 2004, Analytical biochemistry.

[32]  E. Springman,et al.  A Biacore biosensor method for detailed kinetic binding analysis of small molecule inhibitors of p38alpha mitogen-activated protein kinase. , 2004, Analytical biochemistry.

[33]  Yi Hu,et al.  Versatile protein biotinylation strategies for potential high-throughput proteomics. , 2004, Journal of the American Chemical Society.

[34]  C. Ebel Analytical ultracentrifugation for the study of biological macromolecules , 2004 .

[35]  D. L. Taylor,et al.  High content screening applied to large-scale cell biology. , 2004, Trends in biotechnology.

[36]  Silje H. Nordgard,et al.  Direct isolation of recombinant human antibodies against group B Neisseria meningitidis from scFv expression libraries. , 2003, Journal of immunological methods.

[37]  Andreas Sewing,et al.  Fluorescence readouts in HTS: no gain without pain? , 2003, Drug discovery today.

[38]  Matthew A Cooper,et al.  Biosensor profiling of molecular interactions in pharmacology. , 2003, Current opinion in pharmacology.

[39]  B. Shoichet,et al.  A specific mechanism of nonspecific inhibition. , 2003, Journal of medicinal chemistry.

[40]  J Fraser Glickman,et al.  Comparison of Assay Technologies for a Nuclear Receptor Assay Screen Reveals Differences in the Sets of Identified Functional Antagonists , 2003, Journal of biomolecular screening.

[41]  Walter Huber,et al.  Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV. , 2003, Structure.

[42]  Stuart L Schreiber,et al.  Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis. , 2003, Journal of the American Chemical Society.

[43]  N. Johnsson,et al.  Covalent and selective immobilization of fusion proteins. , 2003, Journal of the American Chemical Society.

[44]  W. Niessen,et al.  Progress in liquid chromatography-mass spectrometry instrumentation and its impact on high-throughput screening. , 2003, Journal of chromatography. A.

[45]  Markku Hämäläinen,et al.  Elucidation of HIV-1 protease resistance by characterization of interaction kinetics between inhibitors and enzyme variants. , 2003, Antiviral research.

[46]  David G Myszka,et al.  Characterizing a drug's primary binding site on albumin. , 2003, Journal of pharmaceutical sciences.

[47]  P. Varley,et al.  Screening for glycosylation changes on recombinant human IgG using lectin methods , 2003, Biotechnology and applied biochemistry.

[48]  Alexander Alanine,et al.  Lead generation--enhancing the success of drug discovery by investing in the hit to lead process. , 2003, Combinatorial chemistry & high throughput screening.

[49]  J. Ladbury,et al.  A survey of the year 2002 literature on applications of isothermal titration calorimetry. , 2003, Journal of molecular recognition : JMR.

[50]  D. Myszka,et al.  Analyzing the binding of low molecular mass compounds using Biacore S51 , 2003 .

[51]  T. Hornemann,et al.  Isoenzyme-directed selection and characterization of anti-creatine kinase single chain Fv antibodies from a human phage display library. , 2002, Biochimica et biophysica acta.

[52]  Jean Qiu,et al.  Enhancing the surface sensitivity of colorimetric resonant optical biosensors , 2002 .

[53]  K. Kramer,et al.  Evolutionary affinity and selectivity optimization of a pesticide-selective antibody utlizing a hapten-selective immunoglobulin repertoire. , 2002, Environmental science & technology.

[54]  Manfred Kansy,et al.  Predicting plasma protein binding of drugs: a new approach. , 2002, Biochemical pharmacology.

[55]  Wesley Schaal,et al.  Relationships between structure and interaction kinetics for HIV-1 protease inhibitors. , 2002, Journal of medicinal chemistry.

[56]  Rebecca L Rich,et al.  Kinetic analysis of estrogen receptor/ligand interactions , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[57]  A. Ledin,et al.  Generation of therapeutic antibody responses against IgE through vaccination , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  Rebecca L Rich,et al.  Direct comparison of binding equilibrium, thermodynamic, and rate constants determined by surface‐ and solution‐based biophysical methods , 2002, Protein science : a publication of the Protein Society.

[59]  H R Hoogenboom,et al.  Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein , 2002, British Journal of Cancer.

[60]  R. Karlsson,et al.  A thermodynamic characterization of the binding of thrombin inhibitors to human thrombin, combining biosensor technology, stopped-flow spectrophotometry, and microcalorimetry. , 2002, Analytical biochemistry.

[61]  B. Cunningham,et al.  Colorimetric resonant reflection as a direct biochemical assay technique , 2002, Technical Digest. MEMS 2002 IEEE International Conference. Fifteenth IEEE International Conference on Micro Electro Mechanical Systems (Cat. No.02CH37266).

[62]  J. Marks,et al.  Homogeneous techniques for monitoring receptor-ligand interactions. , 2002, Methods in molecular biology.

[63]  Characterization of drug-plasma protein interactions using surface plasmon resonance , 2002 .

[64]  R. Thurmond,et al.  Kinetics of small molecule inhibitor binding to p38 kinase. , 2001, European journal of biochemistry.

[65]  A Jungbauer,et al.  Transcriptional activities of estrogen receptor alpha and beta in yeast properties of raloxifene. , 2001, Biochemical pharmacology.

[66]  D G Myszka,et al.  High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE. , 2001, Analytical biochemistry.

[67]  L. Old,et al.  Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33. , 2001, Cancer research.

[68]  D G Myszka,et al.  Current and emerging commercial optical biosensors , 2001, Journal of molecular recognition : JMR.

[69]  M. Hämäläinen,et al.  Determination of interaction kinetic constants for HIV-1 protease inhibitors using optical biosensor technology. , 2001, Analytical biochemistry.

[70]  L. Vrang,et al.  Characterization of a Set of HIV-1 Protease Inhibitors Using Binding Kinetics Data from a Biosensor-Based Screen , 2000, Journal of biomolecular screening.

[71]  W. D. Wilson,et al.  Determination of the refractive index increments of small molecules for correction of surface plasmon resonance data. , 2000, Analytical biochemistry.

[72]  Rich,et al.  Implementing surface plasmon resonance biosensors in drug discovery. , 2000, Pharmaceutical science & technology today.

[73]  D. Kostrewa,et al.  Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. , 2000, Journal of medicinal chemistry.

[74]  H Lennernäs,et al.  SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans. , 2000, Journal of medicinal chemistry.

[75]  H Roos,et al.  Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. , 2000, Journal of medicinal chemistry.

[76]  A. Plückthun,et al.  Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. , 2000, Journal of molecular biology.

[77]  M. Hämäläinen,et al.  Biosensor analysis of drug-target interactions: direct and competitive binding assays for investigation of interactions between thrombin and thrombin inhibitors. , 2000, Analytical biochemistry.

[78]  D G Myszka,et al.  Advances in surface plasmon resonance biosensor analysis. , 2000, Current opinion in biotechnology.

[79]  D. Myszka Kinetic, equilibrium, and thermodynamic analysis of macromolecular interactions with BIACORE. , 2000, Methods in enzymology.

[80]  D. Myszka,et al.  Improving biosensor analysis , 1999, Journal of molecular recognition : JMR.

[81]  N. Athanassopoulou,et al.  Cholera Toxin and GMI: A Model membrane study with IAsys , 1999 .

[82]  P. Cohen,et al.  Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. , 1999, The Biochemical journal.

[83]  Jiří Homola,et al.  Surface plasmon resonance sensors based on diffraction gratings and prism couplers: sensitivity comparison , 1999 .

[84]  D Yeung,et al.  Cholera toxin and GM1: a model membrane study with IAsys. , 1999, Biochemical Society transactions.

[85]  H Roos,et al.  Thermodynamic analysis of protein interactions with biosensor technology , 1998, Journal of molecular recognition : JMR.

[86]  E. Saenko,et al.  Activation of Factor VIII by Thrombin Increases Its Affinity for Binding to Synthetic Phospholipid Membranes and Activated Platelets* , 1998, The Journal of Biological Chemistry.

[87]  W. Wang,et al.  The Dependence of Membrane Permeability by the Antibacterial Peptide Cecropin B and Its Analogs, CB-1 and CB-3, on Liposomes of Different Composition* , 1998, The Journal of Biological Chemistry.

[88]  Dustin J Maly,et al.  Probing Low Affinity and Multivalent Interactions with Surface Plasmon Resonance: Ligands for Concanavalin A , 1998 .

[89]  Mats Ohlin,et al.  Characterization of bacteriophages by the use of BIAcore(TM) and Origen Analyzer , 1998 .

[90]  R. Karlsson,et al.  Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. , 1997, Journal of immunological methods.

[91]  A. Minton,et al.  Kinetic analysis of biosensor data: elementary tests for self-consistency. , 1996, Trends in biochemical sciences.

[92]  A. Minton,et al.  Analysis of mass transport-limited binding kinetics in evanescent wave biosensors. , 1996, Analytical biochemistry.

[93]  R C Stevens,et al.  Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance. , 1996, Biochemistry.

[94]  D. Winzor,et al.  Interpretation of deviations from pseudo-first-order kinetic behavior in the characterization of ligand binding by biosensor technology. , 1996, Analytical biochemistry.

[95]  J. Cann,et al.  Demonstration of an upper limit to the range of association rate constants amenable to study by biosensor technology based on surface plasmon resonance. , 1996, Analytical biochemistry.

[96]  R. Karlsson,et al.  Surface plasmon resonance detection and multispot sensing for direct monitoring of interactions involving low-molecular-weight analytes and for determination of low affinities. , 1995, Analytical biochemistry.

[97]  W. Huber,et al.  Determination of kinetic constants for the interaction between the platelet glycoprotein IIb-IIIa and fibrinogen by means of surface plasmon resonance. , 1995, European journal of biochemistry.

[98]  S. Lofas Dextran modified self-assembled monolayer surfaces for use in biointeraction analysis with surface plasmon resonance , 1995 .

[99]  Claus Duschl,et al.  Protein binding to supported lipid membranes: investigation of the cholera toxin-ganglioside interaction by simultaneous impedance spectroscopy and surface plasmon resonance , 1993 .

[100]  G. Whitesides,et al.  Formation of self-assembled monolayers by chemisorption of derivatives of oligo(ethylene glycol) of structure HS(CH2)11(OCH2CH2)mOH on gold , 1991 .

[101]  G. Whitesides,et al.  Modeling Organic Surfaces with Self‐Assembled Monolayers , 1989 .

[102]  H. Raether Surface Plasmons on Smooth and Rough Surfaces and on Gratings , 1988 .

[103]  C. W. Wharton,et al.  Principles and Problems in Physical Chemistry for Biochemists , 1975 .

[104]  E. Kretschmann Die Bestimmung optischer Konstanten von Metallen durch Anregung von Oberflächenplasmaschwingungen , 1971 .

[105]  D. Gerstenberg,et al.  Physics of Thin Films , 1964 .

[106]  A. Herve,et al.  [Radioisotopes in biology]. , 1957, Zeitschrift fur medizinische Isotopenforschung und deren Grenzgebiete.

[107]  C. Kittel Introduction to solid state physics , 1954 .